ClinicalTrials.govpublic full text
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
type 2 diabetes mellitus (t2dm), chronic kidney disease due to type 2 diabetes mellitus, cardiovascular diseases, mineralocorticoid receptor antagonist (mra), type 2 diabetes, chronic kidney disease, diabetic complications, finerenone, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 868856
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.